RELATIVE BIOAVAILABILITY OF 4 MACROCRYSTALLINE NITROFURANTOIN CAPSULES

被引：4

作者：

MASON, WD

CONKLIN, JD

HAILEY, FJ

机构：

[1] NORWICH EATON PHARMACEUT INC,DIV PROD DEV,POB 191,NORWICH,NY 13815

[2] UNIV MISSOURI,SCH PHARM & MED,KANSAS CITY,MO 64108

[3] KANSAS CITY ANALYT SERV,SHAWNEE,KS 66216

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1987年 / 36卷 / 2-3期

关键词：

D O I：

10.1016/0378-5173(87)90144-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：105 / 111

页数：7

共 10 条

[1]

Conklin J D, 1978, Antibiot Chemother (1971), V25, P233

[2]

HAILEY FJ, 1967, CURR THER RES CLIN E, V9, P600

[3] NITROFURANTOIN DISPOSITION [J].

HOENER, BA ;

PATTERSON, SE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (06) :808-816

[4]

MASON WD, IN PRESS ANAL LETT

[5]

METZLER CM, 1985, PC NONLIN STATISTICA

[6] LABORATORY STUDIES WITH NITROFURANTOIN - RELATIONSHIP BETWEEN CRYSTAL SIZE URINARY EXCRETION IN RAT AND MAN AND EMESIS IN DOGS [J].

PAUL, HE ;

HAYES, KJ ;

PAUL, MF ;

BORGMANN, AR .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (07) :882-&

[7]

SCHROEDER FH, 1985, INT C S SERIES, V97

[8]

TURCK M, 1967, ANTIMICROBIAL AGENTS, P446

[9]

WAGNER JG, 1979, FUNDAMENTALS CLIN PH, P175

[10]

1986, WHO BIOAVAILABILITY, P2

← 1 →